Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line–Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients-Reference-Cited by-同舟云学术

Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line–Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients

Published:2019-05 Issue:5 Volume:25 Page:1004-1010
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Ziegler Matthew,Landsburg Daniel,Pegues David,Bilker Warren,Gilmar Cheryl,Kucharczuk Colleen,Gorman Theresa,Bink Kristen,Moore Amy,Fitzpatrick Rebecca,Stadtmauer Edward A.,Mangan Patricia,Kraus Kelly,Han Jennifer H.

Funder

National Institutes of Health

Centers for Disease Control and Prevention

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference39 articles.

1. Multistate point-prevalence survey of health care-associated infections;Magill;N Engl J Med,2014

2. Guidelines for the prevention of intravascular catheter-related infections;O'Grady;Clin Infect Dis,2011

3. Pre-engraftment blood stream infection is a risk factor for acute GVHD grades II-IV;Blennow;Bone Marrow Transplant,2013

4. Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation;Kikuchi;Transpl Infect Dis,2015

5. Defining incidence, risk factors, and impact on survival of central line-associated blood stream infections following hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome;Lukenbill;Biol Blood Marrow Transplant,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementing an Oral Health Educator Contributes to Reduced MBI-CLABSI Rates for Pediatric Hematopoietic Stem Cell Transplant Patients;The Joint Commission Journal on Quality and Patient Safety;2024-07

2. The impact of levofloxacin prophylaxis on empiric intravenous antibiotic use in pediatric hematopoietic stem cell transplant recipients;Pediatric Blood & Cancer;2024-05-09

3. Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review;BMC Cancer;2024-04-19

4. Results of Levofloxacin Prophylaxis Timing in Autologous and Allogeneic Stem Cell Transplantation: A Retrospective Cohort Study;Cureus;2024-04-04

5. The addition of doxycycline to fluoroquinolones for bacterial prophylaxis in autologous stem cell transplantation for multiple myeloma;Transplant Infectious Disease;2024-01-25